|
Title
|
|
|
|
Therapeutic approaches for non-alcoholic steatohepatitis
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have been reported as a novel worldwide epidemic, very often associated with obesity, metabolic syndrome, and type 2 diabetes. Both conditions have also been shown to be associated with a number of endocrine pathologies. Despite the epidemic, the complex pathophysiology and major complications, ranging from metabolic disturbances (diabetes and more) to cardiovascular disease, people with NASH are left with very few management options. The best and most approved therapeutic option is lifestyle intervention. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Therapeutic advances in endocrinology and metabolism. - -
|
|
|
Publication
|
|
|
|
2021
|
|
|
ISSN
|
|
|
|
2042-0188
2042-0196
|
|
|
DOI
|
|
|
|
10.1177/20420188211034300
|
|
|
Volume/pages
|
|
|
|
12
(2021)
, 21 p.
|
|
|
Article Reference
|
|
|
|
20420188211034300
|
|
|
ISI
|
|
|
|
000700383800001
|
|
|
Pubmed ID
|
|
|
|
34497708
|
|
|
Medium
|
|
|
|
E-only publicatie
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|